BENZODIAZEPINE RECEPTOR QUANTIFICATION IN-VIVO IN HUMANS USING [C-11] FLUMAZENIL AND PET - APPLICATION OF THE STEADY-STATE PRINCIPLE

被引:173
|
作者
LASSEN, NA
BARTENSTEIN, PA
LAMMERTSMA, AA
PREVETT, MC
TURTON, DR
LUTHRA, SK
OSMAN, S
BLOOMFIELD, PM
JONES, T
PATSALOS, PN
OCONNELL, MT
DUNCAN, JS
ANDERSEN, JV
机构
[1] NOVO NORDISK AS, DEPT DRUG METAB, DIV CNS, MALOV, DENMARK
[2] HAMMERSMITH HOSP, MRC, CYCLOTRON UNIT, LONDON W12 0HS, ENGLAND
[3] NATL HOSP, DEPT CLIN NEUROL, LONDON WC1N 3BG, ENGLAND
来源
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 1995年 / 15卷 / 01期
关键词
BENZODIAZEPINE RECEPTORS (IN VIVO; FLUMAZENIL; POSITRON EMISSION TOMOGRAPHY; RO; 15-1788;
D O I
10.1038/jcbfm.1995.17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carbon-11-labeled flumazenil combined with positron emission tomography (PET) was used to measure the concentration (B-max) of the benzodiazepine (Bz) receptor in the brain and its equilibrium dissociation constant (K-D) for flumazenil in five normal subjects. The steady-state approach was used injecting the tracer as a bolus of high specific activity. In each subject two studies were carried out. The first study was performed at essentially zero receptor occupancy, the tracer alone study. The second study was performed at a steady-state receptor occupancy of about 50%, achieved by a prolonged constant infusion of nonlabeled (''cold'') flumazenil starting 2 h before the bolus tracer injection and continuing until the end of the scanning period. In this second study the free concentration of unmetabolized flumazenil in plasma water was measured in multiple blood samples. The observed tissue and plasma tracer curves, calibrated in the same units of radioactivity per millimeter, were analyzed in two ways: (a) by the noncompartmental (stochastic) approach making no assumptions regarding number of compartments in the tissue, and (b) by the single-compartment approach assuming rapid exchange (mixing) of tracer between all tissue compartments. The noncompartmental and the compartmental analyses gave essentially the same values for the distribution volume of the tracer, the parameter used for quantitation of the Bz receptor. As the compartmental approach could be applied to a shorter observation period (60 min instead of 120 min) it was preferred. The five subjects had a mean K-D value of 12 nM/L of water and B-max values of the grey matter ranging from 39 +/- 11 in thalamus to 120 +/- 14 nM/L of brain in occipital cortex. Most previous studies have been based on the pseudoequilibrium approach using the brain stem as a receptor-free reference region. This yields practically the same K-D but lower B-max values than the steady-state approach presented here.
引用
收藏
页码:152 / 165
页数:14
相关论文
共 50 条
  • [21] COMPARISON OF [C-11] DIPRENORPHINE AND [C-11] CARFENTANIL IN-VIVO BINDING TO OPIATE RECEPTORS IN MAN USING A DUAL DETECTOR SYSTEM
    VILLEMAGNE, VL
    FROST, JJ
    DANNALS, RF
    LEVER, JR
    TANADA, S
    NATARAJAN, TK
    WILSON, AA
    RAVERT, HT
    WAGNER, HN
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 257 (1-2) : 195 - 197
  • [22] MODELING ANALYSIS OF [C-11] FLUMAZENIL KINETICS STUDIED BY PET - APPLICATION TO A CRITICAL-STUDY OF THE EQUILIBRIUM APPROACHES
    DELFORGE, J
    SYROTA, A
    BOTTLAENDER, M
    VARASTET, M
    LOCH, C
    BENDRIEM, B
    CROUZEL, C
    BROUILLET, E
    MAZIERE, M
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (03): : 454 - 468
  • [23] Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans
    Parsey, Ramin V.
    Ojha, Ashish
    Ogden, R. Todd
    Erlandsson, Kjell
    Kumar, Dileep
    Landgrebe, Marguerite
    Van Heertum, Ronald
    Mann, J. John
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (11) : 1796 - 1802
  • [24] SYNTHESIS, IN-VIVO BIODISTRIBUTION AND DOSIMETRY OF [C-11] N-METHYLPIPERIDYL BENZILATE ([C-11]NMPB), A MUSCARINIC ACETYLCHOLINE-RECEPTOR ANTAGONIST
    MULHOLLAND, GK
    KILBOURN, MR
    SHERMAN, P
    CAREY, JE
    FREY, KA
    KOEPPE, RA
    KUHL, DE
    NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (01): : 13 - 17
  • [25] LABELING OF POLYSACCHARIDES USING [C-11] CYANOGEN-BROMIDE - IN-VIVO AND IN-VITRO EVALUATION OF C-11 HYALURONAN UPTAKE KINETICS
    WESTERBERG, G
    BERGSTROM, M
    GUSTAFSON, S
    LINDQVIST, U
    SUNDIN, A
    LANGSTROM, B
    NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (02) : 251 - 256
  • [26] Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF
    Ohyama, M
    Senda, M
    Ishiwata, K
    Kitamura, S
    Mishina, M
    Ishii, K
    Toyama, H
    Oda, K
    Katayama, Y
    ANNALS OF NUCLEAR MEDICINE, 1999, 13 (05) : 309 - 315
  • [27] GABA-benzodiazepine receptor function in alcohol dependence:: a combined 11C-flumazenil PET and pharmacodynamic study
    Lingford-Hughes, AR
    Wilson, SJ
    Cunningham, VJ
    Feeney, A
    Stevenson, B
    Brooks, DJ
    Nutt, DJ
    PSYCHOPHARMACOLOGY, 2005, 180 (04) : 595 - 606
  • [28] GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study
    A. R. Lingford-Hughes
    S. J. Wilson
    V. J. Cunningham
    A. Feeney
    B. Stevenson
    D. J. Brooks
    D. J. Nutt
    Psychopharmacology, 2005, 180 : 595 - 606
  • [29] IN-VIVO ESTIMATES OF SYNAPTIC DOPAMINE CONCENTRATIONS WITH C-11 RACLOPRIDE/PET - A DIRECT TEST OF THE DOPAMINE HYPOTHESIS
    BREIER, A
    CARSON, R
    ECKELMAN, W
    DEBARTOLOMEIS, A
    SAUNDERS, RC
    WEINBERGER, D
    SU, TP
    PICKAR, D
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 76 - 77
  • [30] Preserved benzodiazepine receptors in Alzheimer’s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF
    Masashi Ohyama
    Michio Senda
    Kiichi Ishiwata
    Shin Kitamura
    Masahiro Mishina
    Kenji Ishii
    Hinako Toyama
    Keiichi Oda
    Yasuo Katayama
    Annals of Nuclear Medicine, 1999, 13 : 309 - 315